The DOI matches its Crossref record; 320 of the 320 references it cites were found in a registry or an index.
The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Abstract
Peroxisome proliferator-activated receptors (PPARs) are ligand activated transcription factors that modulate target gene expression in response to endogenous and exogenous ligands. Ligands for the PPARs have been widely developed for the treatment of various diseases including dyslipidemias and diabetes. While targeting selective receptor activation is an established therapeutic approach for the treatment of various diseases, a variety of toxicities are known to occur in response to ligand administration. Whether PPAR ligands produce toxicity via a receptor-dependent and/or off-target-mediated mechanism(s) is not always known. Extrapolation of data derived from animal models and/or in vitro models, to humans, is also questionable. The different toxicities and mechanisms associated with administration of ligands for the three PPARs will be discussed, and important data gaps that could increase our current understanding of how PPAR ligands lead to toxicity will be highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–320 of 320
Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
Yamamoto, Y., Yamazaki, H., Ikeda, T., Watanabe, T., Iwabuchi, H., Nakajima, M., & Yokoi, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.155 · Cited by 84
Yang, F., Zhang, Z., Xin, D., Shi, C.-J., Wu, J., Guo, Y., & Guan, Y. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00753.x · Cited by 82
Peroxisome Proliferator-Activated Receptor γ Controls Muc1 Transcription in Trophoblasts
Shalom‐Barak, T., Nicholas, J. M., Wang, Y., Zhang, X., Ong, E. S., Young, T. H., Gendler, S. J., Evans, R. M., & Barak, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10661-10669.2004 · Cited by 81
Suppression of Prostate Tumor Cell Growth by Stromal Cell Prostaglandin D Synthase–Derived Products
Kim, J., Yang, P., Suraokar, M. B., Sabichi, A. L., Llansa, N., Mendoza, G., Subbarayan, V., Logothetis, C. J., Newman, R. A., Lippman, S. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4439 · Cited by 80
Anderson, S. P., Howroyd, P. C., Liu, J., Qian, X., Bahnemann, R., Swanson, C. L., Kwak, M.-K., Kensler, T. W., & Corton, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409347200 · Cited by 79
Fröhlich, E., Machicao, F., & Whal, R. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00973 · Cited by 79
Hong, J. Y., Samudio, I. J., Liu, S., Abdelrahim, M., & Safe, S. H. (2004) · Endocrinology · doi:10.1210/en.2004-0686 · Cited by 79
Liu, R. C. M. (1996) · Fundamental and Applied Toxicology · doi:10.1006/faat.1996.0059 · Cited by 78
Effects of Gemfibrozil and Other Fibric Acid Derivatives on Blood Lipids and Lipoproteins
ZIMETBAUM, P. J., Frishman, W. H., & Kahn, S. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb01883.x · Cited by 78
Han, S. W., Greene, M. E., Pitts, J., Wada, R. K., & Sidell, N. (2001) · PubMed · Cited by 77
Kim, E. J., Park, K. S., Chung, S. Y., Sheen, Y. Y., Moon, D. C., Song, Y. S., Kim, K. S., Song, S., Yun, Y. P., Lee, M. K., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053876 · Cited by 77
Betz, M. J., Shapiro, I., Faßnacht, M., Hahner, S., Reincke, M., & Beuschlein, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1267 · Cited by 76
Chen, C.-S. (2000) · Toxicological Sciences · doi:10.1093/toxsci/57.2.338 · Cited by 76
Scatena, R., Bottoni, P., Martorana, G. E., Ferrari, F., Sole, P. D., Rossi, C., & Giardina, B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.072 · Cited by 75
Yang, K., Fan, K., Lamprecht, S. A., Edelmann, W., Kopelovich, L., Kucherlapati, R., & Lipkin, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21018 · Cited by 73
Yarış, F., Yariş, E., Kadıoğlu, M., Ulku, C., Kesim, M., & Kalyoncu, N. İ. (2004) · Reproductive Toxicology · doi:10.1016/j.reprotox.2004.02.014 · Cited by 73
Role of Fibrates and HMG-CoA Reductase Inhibitors in Gallstone Formation
Caroli‐Bosc, F., Gall, P. L., Puglièse, P., Delabre, B., Caroli-Bosc, C., Demarquay, J.-F., Delmont, J.-P., Rampal, P., & Montet, J. C. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1005643014395 · Cited by 71
Growth Inhibition and Differentiation of Pancreatic Cancer Cell Lines by PPARγ Ligand Troglitazone
Kawa, S., Nikaido, T., Unno, H., Usuda, N., Nakayama, K., & Kiyosawa, K. (2002) · Pancreas · doi:10.1097/00006676-200201000-00001 · Cited by 71
The effect of peroxisome proliferators on mitochondrial bioenergetics
Zhou, S., & Wallace, K. B. (1999) · Toxicological Sciences · doi:10.1093/toxsci/48.1.82 · Cited by 71
Lampen, A., Zimnik, S., & Nau, H. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00014-0 · Cited by 70
Lu, J., Imamura, K., Nomura, S., Mafune, K., Nakajima, A., Kadowaki, T., Kubota, N., Terauchi, Y., Ishii, G., Ochiai, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2293 · Cited by 70
Clofibrate therapy and gallstone induction
Bateson, M. C., Maclean, D., Ross, P. E., & Bouchier, I. A. D. (1978) · Digestive Diseases and Sciences · doi:10.1007/bf01072597 · Cited by 69
Clofibrate Pretreatment Diminishes Acetaminophen′s Selective Covalent Binding and Hepatotoxicity
Manautou, J. E., Hoivik, D. J., Tveit, A., HART, S. G. E., Khairallah, E. A., & Cohen, S. D. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1250 · Cited by 69
(2004) · PubMed · Cited by 69
Fukumoto, K., Yano, Y., Virgona, N., Hagiwara, H., Sato, H., Senba, H., Suzuki, K., Asano, R., Yamada, K., & Yano, T. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.004 · Cited by 68
Severe Hepatotoxicity Associated with Troglitazone
Herrine, S. K., & Choudhary, C. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-2-199901190-00021 · Cited by 68
Kato, M., Kusumi, T., Tsuchida, S., Tanaka, M., Sasaki, M., & Kudo, H. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0510-2 · Cited by 68
Magarian, G. J., Lucas, L. M., & Colley, C. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400090143027 · Cited by 67
The Direct Effect of Hepatic Peroxisome Proliferators on Rat Leydig Cell Functionin Vitro
Liu, R. (1996) · Fundamental and Applied Toxicology · doi:10.1006/faat.1996.0047 · Cited by 67
Straková, N., Ehrmann, J., Bartoš, J., Malíková, J., Doležel, J., & Kolar, Z. (2005) · PubMed · Cited by 65
Hase, T., Yoshimura, R., Mitsuhashi, M., Segawa, Y., Kawahito, Y., Wada, S., Nakatani, T., & Sano, H. (2002) · Urology · doi:10.1016/s0090-4295(02)01747-8 · Cited by 65
Sabatino, L., Casamassimi, A., Peluso, G., Barone, M. V., Capaccio, D., Migliore, C., Bonelli, P., Pedicini, A., Febbraro, A., Ciccodicola, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502716200 · Cited by 65
Hellemans, K., Rombouts, K., Quartier, E., Dittié, A. S., Knorr, A., Michalik, L., Rogiers, V., Schuit, F., Wahli, W., & Geerts, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200376-jlr200 · Cited by 64
Li, M., Lee, T. W., Mok, T. S. K., Warner, T. D., Yim, A. P. C., & Chen, G. G. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20474 · Cited by 63
Tanaka, K., Smith, P. F., Stromberg, P. C., et al. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90146-j · Cited by 63
Werling, U., Siehler, S., Litfin, M., Nau, H., & Göttlicher, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1269 · Cited by 63
PPARγ ligand‐induced apoptosis through a p53‐dependent mechanism in human gastric cancer cells
Nagamine, M., Okumura, T., Tanno, S., Sawamukai, M., Motomura, W., Takahashi, N., & Kongo, Y. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01443.x · Cited by 62
Göke, R., Göke, A., Göke, B., El‐Deiry, W. S., & Chen, Y. (2001) · Digestion · doi:10.1159/000048843 · Cited by 62
Straková, N., Ehrmann, J., Džubák, P., Bouchal, J., & Kolář, Z. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063438 · Cited by 62
Ramachandran, V., Kostrubsky, V. E., Komoroski, B. J., Zhang, S., Dorko, K., Esplen, J. E., Strom, S. C., & Venkataramanan, R. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15045-3 · Cited by 62
Roberta Morosetti, A., Servidei, T., Massimiliano Mirabella, A., Rutella, S., Mangiola, A., Maira, G., Mastrangelo, R., & Koeffler, H. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.2.493 · Cited by 61
Lampen, A., Siehler, S., Ellerbeck, U., Göttlicher, M., & Nau, H. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8770 · Cited by 61
Turturro, F., Friday, E., Fowler, R., Surie, D., & Welbourne, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0879 · Cited by 61
Holst, D. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00179-4 · Cited by 60
Shankar, K., Vaidya, V. S., Corton, J. C., Bucci, T. J., Liu, J., Waalkes, M. P., & Mehendale, H. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1186fje · Cited by 60
Matthiessen, M. W., Pedersen, G., Albrektsen, T., Adamsen, S., Fleckner, J., & Brynskov, J. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410009573 · Cited by 59
Han, S., Wada, R. K., & Sidell, N. (2001) · PubMed · Cited by 59
Pignatelli, M., Cortés‐Canteli, M., Lai, C., Santos, Á., & Pérez‐Castillo, A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.22.4117 · Cited by 58
Teratogenicity/Fetotoxicity of DEHP in Mice
Tomita, I., Nakamura, Y., Yagi, Y., & Tutikawa, K. (1982) · Environmental Health Perspectives · doi:10.1289/ehp.824571 · Cited by 58
James, S. Y., Lin, F., Kolluri, S. K., Dawson, M. I., & Zhang, X.-K. (2003) · PubMed · Cited by 56
Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation
Keller, B., Marsman, D. S., Popp, J. A., & Thurman, R. G. (1992) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(92)90105-b · Cited by 56
PPAR‐γ‐Mediated Regulation of Normal and Malignant B Lineage Cells
Padilla, J., Kaur, K., Harris, S. G., & Phipps, R. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06542.x · Cited by 55
Ray, D. M., Bernstein, S. H., & Phipps, R. P. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.06.011 · Cited by 55
Chung, S.-H., Onoda, N., Ishikawa, T., Ogisawa, K., Takenaka, C., Yano, Y., Hato, F., & Hirakawa, K. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01245.x · Cited by 55
PPARγ‐dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF)
Cimini, A., Cristiano, L., Colafarina, S., Benedetti, E., Loreto, S. D., Festuccia, C., Amicarelli, F., Canuto, R. A., & Cerù, M. P. (2005) · International Journal of Cancer · doi:10.1002/ijc.21272 · Cited by 55
Lampen, A., Carlberg, C., & Nau, H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01423-6 · Cited by 53
A case of rosiglitazone exposure in the second trimester of pregnancy
Kalyoncu, N. İ., Yarış, F., Ulku, C., Kadıoğlu, M., Kesim, M., Unsal, M. A., Dikici, M. F., & Yariş, E. (2004) · Reproductive Toxicology · doi:10.1016/j.reprotox.2004.11.003 · Cited by 52
Shaik, M. S., Chatterjee, A., & Singh, M. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0902-03 · Cited by 52
Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil
Bermingham, R. P., Whitsitt, T. B., Smart, M. L., Nowak, D., & Scalley, R. D. (2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.5.461 · Cited by 52
Klopper, J. P., Hays, W. R., Sharma, V., Baumbusch, M. A., Hershman, J. M., & Haugen, B. R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1011.3.8 · Cited by 52
Selective Intranuclear Redistribution of PPAR Isoforms by RXR
Akiyama, T. E., Baumann, C. T., Sakai, S., Hager, G. L., & Gonzalez, F. J. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0797 · Cited by 50
Self-citationZhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzales, F., & Yang, T. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090935 · Cited by 50
Chen, Z. Y., & Tseng, C. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014944 · Cited by 50
Klopper, J. P., Hays, W. R., Sharma, V., Baumbusch, M. A., Hershman, J. M., & Haugen, B. R. (2004) · PubMed · Cited by 49
Leiß, O., Meyer-Krahmer, K., & von Bergmann, K. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38795-2 · Cited by 48
Gallagher, E. P., Buetler, T. M., Stapleton, P. L., WANG, C., Stahl, D., & Eaton, D. L. (1995) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1995.1171 · Cited by 48
DI(2-ethylhexyl)phthalate-induced changes in liver estrogen metabolism and hyperplasia
Eagon, P. K., Chandar, N., Epley, M. J., Elm, M. S., Brady, E. P., & Rao, K. N. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580519 · Cited by 48
Fenofibrate induced-rhabdomyolysis in two dialysis patients with hypothyroidism
Clouâtre, Y., Leblanc, M., Ouimet, D., & Pichette, V. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.4.1047 · Cited by 48
The effect of PPAR?? ligands on the proliferation and apoptosis of human melanoma cells
Placha, W., Gil, D., ska-Kie, A. D., & Laidler, P. M. (2003) · Melanoma Research · doi:10.1097/00008390-200310000-00003 · Cited by 47
Han, S., Ritzenthaler, J. D., Rivera, H. N., & Roman, J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00002.2005 · Cited by 44
Manautou, J. E., Silva, V. M., Hennig, G. E., & Whiteley, H. E. (1998) · Toxicology · doi:10.1016/s0300-483x(98)00013-4 · Cited by 43
Scatena, R., Bottoni, P., Vincenzoni, F., Messana, I., Martorana, G. E., Nocca, G., Sole, P. D., Maggiano, N., Castagnola, M., & Giardina, B. (2003) · Chemical Research in Toxicology · doi:10.1021/tx0341052 · Cited by 43
Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma
Jung, T.-I., Baek, W., Suh, S., Jang, B., Song, D., Bae, J., Kwon, K., Bae, J.-H., Cha, S.-D., Bae, I., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.01.019 · Cited by 42
The mitochondrial respiratory complex I is a target for 15-deoxy-Δ12,14-prostaglandin J2 action
Martínez, B., Pérez‐Castillo, A., & Santos, Á. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400392-jlr200 · Cited by 41
Ohta, T., Elnemr, A., Yamamoto, M., Ninomiya, I., Fushida, S., Nishimura, G., Fujimura, T., Kitagawa, H., Kayahara, M., Shimizu, K., et al. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.1.37 · Cited by 39
Scatena, R., Martorana, G. E., Bottoni, P., & Giardina, B. (2004) · IUBMB Life · doi:10.1080/15216540400008416 · Cited by 38
Ohata, M., Suzuki, H., Sakamoto, K., Hashimoto, K., Nakajima, H., Yamauchi, M., Hokkyo, K., Yamada, H., & Toda, G. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000134412.38510.f7 · Cited by 38
Fenofibrate Monotherapy Induced Rhabdomyolysis
Barker, B. J., Goodenough, R. R., & Falko, J. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2482 · Cited by 36
Valentiner, U., Carlsson, M., Erttmann, R., Hildebrandt, H., & Schumacher, U. (2005) · Toxicology · doi:10.1016/j.tox.2005.05.024 · Cited by 35
He, G., Thuillier, P., & Fischer, S. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23465.x · Cited by 35
Pino, M. V., Kelley, M. F., & Jayyosi, Z. (2004) · Toxicologic Pathology · doi:10.1080/01926230490261320 · Cited by 35
PPAR?-dependent modulation of hepatic CYP1A by clofibric acid in rats
Shaban, Z., El-Shazly, S. A., Ishizuka, M., Kimura, K., Kazusaka, A., & Fujita, S. (2004) · Archives of Toxicology · doi:10.1007/s00204-004-0569-9 · Cited by 35
Peroxisome proliferators protect against paracetamol hepatotoxicity in mice
Nicholls-Grzemski, F. A., Calder, I. C., & Priestly, B. G. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90193-m · Cited by 34
Liu, J., Lin, S., Ho, Y., Pan, S., Hung, L.-F., Tsai, S., Lin, J., & Liang, Y. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10119 · Cited by 33
Subbarayan, V., Sabichi, A. L., Kim, J., et al. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1710.13.11 · Cited by 33
Troglitazione affects survival of human osteosarcoma cells
Lucarelli, E., Sangiorgi, L., Maini, V., Lattanzi, G., Marmiroli, S., Reggiani, M., Mordenti, M., Gobbi, G., Scrimieri, F., Bertoja, A. Z., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10203 · Cited by 32
Michalik, L., Feige, J. N., Gelman, L., Pedrazzini, T., Keller, H., Desvergne, B., & Wahli, W. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0068 · Cited by 32
MEHP/DEHP: Gonadal Toxicity and Effects on Rodent Accessory Sex Organs
Thomas, J. A., Curto, K. A., & Thomas, M. J. (1982) · Environmental Health Perspectives · doi:10.1289/ehp.824585 · Cited by 31
Rumi, M. A. K., Sato, H., Ishihara, S., Ortega, C., Kadowaki, Y., & Kinoshita, Y. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.125055 · Cited by 29
Clofibrate myopathy: A case report and a review of the literature
Rush, P. J., Baron, M. G., & Kapusta, M. A. (1986) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(86)90019-3 · Cited by 29
Rhabdomyolysis and Renal Failure Associated with Gemfibrozil Monotherapy
Layne, R. D., Sehbai, A. S., & Stark, L. J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d282 · Cited by 29
Fauti, T., Müller‐Brüsselbach, S., Kreutzer, M., Rieck, M., Meißner, W., Rapp, U. R., Schweer, H., Kömhoff, M., & Müller, R. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05055.x · Cited by 28
Nikolaidis, L. A., & Levine, T. B. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000102419.52594.90 · Cited by 26
Lampen, A., Grimaldi, P. A., & Nau, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009340 · Cited by 26
Bezafibrat-induzierte Myolyse und Myoglobinurie bei Patienten mit eingeschränkter Nierenfunktion
Rumpf, K. W., Barth, M., Blech, M., Kaiser, H., Koop, I., Arnold, R., & Scheler, F. (1984) · Journal of Molecular Medicine · doi:10.1007/bf01716252 · Cited by 25
Budman, D. R., & Calabro, A. R. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00008 · Cited by 24
Troglitazone Induces CYP3A4 Activity Leading to Falsely Abnormal Dexamethasone Suppression Test
Dimaraki, E. V., & Jaffe, C. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021778 · Cited by 24
RODWAY, H. A., Hunt, A. N., Kohler, J., Postle, A. D., & Lillycrop, K. A. (2004) · Biochemical Journal · doi:10.1042/bj20040107 · Cited by 23
Weissman, N., Heidemann, H., Bock, K. D., & Kreuzfelder, E. (1981) · Journal of Molecular Medicine · doi:10.1007/bf01698522 · Cited by 23
Maternal Clofibrate Administration Amplifies Fetal Peroxisomes
Wilson, G. N., King, T., Argyle, J. C., & Garcia, R. F. (1991) · Pediatric Research · doi:10.1203/00006450-199103000-00007 · Cited by 23
Fujii, D., Yoshida, K., Tanabe, K., Hihara, J., & Toge, T. (2004) · PubMed · Cited by 22
Cibelli, A., Stefanini, S., & Cerù, M. (1988) · PubMed · Cited by 22
The Nongenotoxic Hepatocarcinogen Wy-14,643 Is an Uncoupler of Oxidative Phosphorylation in Vivo
Keller, B. J., Bradford, B. U., Marsman, D. S., Cattley, R. C., Popp, J. A., Bojes, H. K., & Thurman, R. G. (1993) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1993.1043 · Cited by 21
Vosper, H., Khoudoli, G. A., & Palmer, C. N. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-9 · Cited by 21
The Cellular Response to PPARγ Ligands Is Related to the Phenotype of Neuroblastoma Cell Lines
Servidei, T., Roberta Morosetti, A., Ferlini, C., Cusano, G., Scambia, G., Mastrangelo, R., & Koeffler, H. P. (2004) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/0965040041292297 · Cited by 20
Chen, F., & Harrison, L. E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.08.008 · Cited by 18
Experimental studies on reproduction with the lipid-regulating agent gemfibrozil
FITZGERALD, J. (1987) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(87)90131-x · Cited by 18
Stefanini, S., Mauriello, A., Farrace, M. G., Cibelli, A., & Cerù, M. P. (1989) · Biology of the Cell · doi:10.1111/j.1768-322x.1989.tb00875.x · Cited by 17
Bezafibrate induced rhabdomyolysis.
Kanterewicz, E., Sanmartí, R., Riba, J., Trias, I., Autonell, J., & Brugués, J. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.4.536 · Cited by 17
Emmans, V. C., RODWAY, H. A., Hunt, A. N., & Lillycrop, K. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320840 · Cited by 15
Effects of fenofibrate on bile lipid composition.
Palmer, R. H. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.6.631 · Cited by 15
[Fenofibrate: animal toxicology in relation to side-effects in man (author's transl)].
Blane, G. F., & Pinaroli, F. (1980) · PubMed · Cited by 14
Raedsch, R., Plachky, J., Wolf, N. I., et al. (1995) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03226364 · Cited by 13
Sasaki, T., Fujimoto, Y., Tsuchida, A., Kawasaki, Y., Kuwada, Y., & Chayama, K. (2001) · Pathobiology · doi:10.1159/000064336 · Cited by 13
Recent Advances in Peroxisome Proliferator- Activated Receptor Science
Shearer, B. G., & Hoekstra, W. J. (2005) · Frontiers in Medicinal Chemistry - Online · doi:10.2174/1567204052930970 · Cited by 13
Rhabdomyolysis and acute renal failure associated with bezafibrate treatment
Górriz, J. L., Sancho, A., Alcoy, E., García-Ramos, J. L., & Pallardó, L. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.12.2371b · Cited by 12
Effect of Gemfibrozil Administration on Biliary Lipid Secretion in Hyperlipidemic Patients
Mazzella, G., Bazzoli, F., Villanova, N., Simoni, P., Festi, D., Roda, A., Aldini, R., & Roda, E. (1990) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529008998558 · Cited by 8
Zhang, M., Zou, P., Bai, M., et al. (2003) · PubMed · Cited by 4
[Studies of the interactions of clofibrate with the reproductive function].
Gc, P., & VALERI, P. (1974) · PubMed · Cited by 4
Ohata, M., Suzuki, H., Sakamoto, K., Hashimoto, K., Nakajima, H., Yamauchi, M., Hokkyo, K., Yamada, H., & Toda, G. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2004.tb03232.x · Cited by 4
Cited by
Targeting metabolic dysregulation for fibrosis therapy
Zhao, X., Kwan, J. Y. Y., Yip, K., Liu, P. P., & Liu, F.-F. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 513
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Peters, J. M., Shah, Y. M., & Gonzalez, F. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3214 · Cited by 492
Self-citationTakacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396
Omiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H., & Peters, J. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq338 · Cited by 369
Self-citationModes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver
Rusyn, I., Peters, J. M., & Cunningham, M. L. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440600779065 · Cited by 301
Self-citation
Metadata
- Authors
- Peraza, M. A., Burdick, A. D., Marin, H. E., Gonzalez, F. J., & Peters, J. M.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 90
- Issue
- 2
- Pages
- 269-295
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2170985017
- Cited by
- 254
- References
- 320
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.